Absence of the G Protein-coupled Receptor G2A in Mice Promotes Monocyte/endothelial Interactions in Aorta
Overview
Affiliations
The G protein-coupled receptor G2A is highly expressed on macrophages and lymphocytes and has been localized to atherosclerotic plaques. We examined the role of G2A in modulating monocyte/endothelial interactions in the vessel wall. We measured adhesion of WEHI 78/24 monocytes to aortas of C57BL/6 (B6) and G2A-deficient (G2A(-/-)) mice using an ex vivo adhesion assay. G2A(-/-) mice had 10-fold elevations in adhesion of monocytes to aortas. Injection of GFP-expressing wild-type macrophages into B6 and G2A(-/-) mice in vivo showed increased macrophage accumulation in the aortic wall of G2A(-/-) mice. We isolated aortic endothelial cells (ECs) from B6 and G2A(-/-) mice and found a 2-fold increase in intercellular adhesion molecule-1 and E-selectin surface expression on G2A(-/-) ECs using flow cytometry. Using ELISA, we found a 3-fold increase in interleukin-6 and monocyte chemoattractant protein-1 production by G2A(-/-) ECs compared with B6 ECs. We found a dramatic increase in nuclear localization of the p65 subunit of nuclear factor kappaB in G2A(-/-) ECs. Transfection of G2A into G2A(-/-) ECs to restore normal expression levels reduced p65 nuclear localization to 35%. Restoration of G2A expression in G2A(-/-) ECs significantly reduced intercellular adhesion molecule-1 and endothelial selectin surface expression and reduced monocyte chemoattractant protein-1 and interleukin-6 production. Restoring G2A to G2A(-/-) ECs reduced monocyte adhesion by 80% compared with G2A(-/-) ECs in a flow chamber assay. Absence of G2A in endothelium results in proinflammatory signaling and increased monocyte/endothelial interactions in the aortic wall. Thus, endothelial G2A expression may aid in prevention of vascular inflammation and atherosclerosis.
Cui X, Xing R, Tian Y, Wang M, Sun Y, Xu Y Front Physiol. 2021; 12:659211.
PMID: 34381373 PMC: 8351205. DOI: 10.3389/fphys.2021.659211.
Zhang Q, Zhang W, Liu J, Yang H, Hu Y, Zhang M Bioengineered. 2021; 12(1):4520-4535.
PMID: 34346841 PMC: 8806654. DOI: 10.1080/21655979.2021.1956671.
Efferocytosis of vascular cells in cardiovascular disease.
Cabrera J, Makino A Pharmacol Ther. 2021; 229:107919.
PMID: 34171333 PMC: 8695637. DOI: 10.1016/j.pharmthera.2021.107919.
Ledwaba S, Costa D, Bolick D, Giallourou N, Medeiros P, Swann J Front Cell Infect Microbiol. 2021; 10:595266.
PMID: 33392105 PMC: 7773950. DOI: 10.3389/fcimb.2020.595266.
Li H, Jang J, Jung J, Shin J, Park C, Kim Y J Immunol. 2018; 202(2):527-538.
PMID: 30530591 PMC: 6477683. DOI: 10.4049/jimmunol.1700783.